Lantern Pharma Inc. business relationships

Companies named in Lantern Pharma Inc.’s 10-K filed 2026-03-30, and public companies whose annual reports name Lantern Pharma Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 6.1 / 10
AI naming: 100 / 100
Agent readiness: 5 / 100
AI adoption: 2 / 100

Named in Lantern Pharma Inc.’s annual report 3

Allarity Therapeutics, Inc. (ALLR)Licensee4.7
“LP-100 was previously out-licensed by us to Allarity Therapeutics A/S.” SEC filing
ACTUATE THERAPEUTICS, INC. (ACTU)Partner4.7
“May 2021, we entered into a Collaboration Agreement with Actuate Therapeutics, Inc. ("Actuate"), a clinical stage private” SEC filing
AF Chemicals, LLCLicensor3.5
“License Agreement dated January 15, 2015, with AF Chemicals, LLC |” SEC filing

Companies whose annual reports name Lantern Pharma Inc. 1

ACTUATE THERAPEUTICS, INC. (ACTU)names it as partner4.7
“As part of the collaboration, Lantern Pharma received 13,889 restricted” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.